IHL-675A is currently still in the Pre-Clinical Stage. The BOD are crafting a development plan for it's Stage 1 - Human Trial.
This announcement is both for the preparation of a SoftGel capsule for the upcoming human trials and potentially future commercial production subject to it's success. Procaps is equipped to provide an end-to-end service that includes formulation development, clinical trial supply and subsequent commercial manufacture.